MicroMED at a Glance
Established in 2016, MicroMED Co Ltd is a medtech company located in Taipei, Taiwan, specializing in the design and manufacturing of MEMS-enabled drug delivery systems (DDS). Our company's core technology is built upon a diverse portfolio of 50+ MEMS intellectual properties and know-how, spanning across 10 countries/regions worldwide. We have successfully validated our MEMS technology with six prominent biopharmaceutical and medical device clients from the US and EU, with ongoing collaborative projects.
Our business model, based on our core technology, has a two-pronged approach:
◆ MEMS engine (component)
● Development and manufacturing
● Supply to BioPharma and Device Clients
◆ Final DDS (system)
● Development and manufacturing
● Direct supply to BioPharma Client
● Partner with device co to supply to BioPharma
Our Mission
To provide an electrochemical/MEMS enabled compact precision pneumatic actuation system for the leading-edge drug delivery industry.
We aim to become a new platform beyond the traditional spring/motor driving systems that enables the true fulfillment of the ever-evolving requirements of the wider range of dose volumes/concentrations of biologic drugs for subcutaneous and other non-traditional routes/form factors of drug delivery devices.
Spring & Motor Buster
Primary Actuator® addresses all new subcutaneous administration trends that springs and motors cannot address.
Quality Policy
We consistently provide customers with the highest quality products and services that comply with regulations and meet the requirements of safety, effectiveness, and precision medicine
Quality Commitment
Our commitment in quality policy is to develop and manufacture the highest quality drug administration products to meet our bio-pharmaceutical/medical device customers’ expectation beyond safety and efficacy.
Quality Certification
Certification: ISO 13485:2016
Certification Body: DNV Product Assurance AS
Certification Number: C606708
Date of Certification: Feb 12, 2024
Certified Scope:
Design, Manufacture, Servicing,
Sales and Distribution of Primary Actuator for Drug Delivery
Intellectual Property
MicroMED holds 8 current IP families and trade secrete/know-hows in our innovative MEMS technology including “reusable” drug delivery system design, microchip design, fabrication process, control algorithm, and actuation technique, etc.
-
51 total applications, 14 issued patents
-
10 countries/areas (US, PCT, TW, CN, EP, JP, KR, IN, MY AU)
Partnership
We welcome partnerships throughout the drug delivery value chain, including biopharmaceutical companies, medical device developers, and insurance payers. This can be achieved through the purchase of our existing actuator products, co-development of advanced injector products, or licensing our proprietary micro-engine technology and intellectual properties.
The co-development process for advanced injector products follows a phase/milestone-based approach:
-
Preclinical / Feasibility Assessment
-
Collaboration / Development Agreement
-
Manufacturing / Commercial-Supply Agreement
Our History
2016
Preclinical Pump
Core MEMS Microchip Development
2020
Primary Actuator
MEMS Engine Platform for SC Injectors
2021
2.25mL Autoinjector
Large-Volume Autoinjector Prototype
2022
5.0mL Autoinjector
Ultra Large-Volume Autoinjector Prototype
2023
10mL On-Body
Injector
Large-Volume
Wearable System
Oral Adm.
Smart/digital Pill
Micropump
Targeted delivery
2024
ISO 13485 Certification is expected in early 2024
Leadership
Executive Team
Brian Li, PhD
Founder, Chairman, and CEO
Brian has 18+ years of experiences in both business and engineering development with drug delivery startups in ophthalmology and biotechnology in the U.S. Before starting up MicroMED, he was the project lead for a technology transfer program in Alcon helping deal negotiation and technology transfer to Alcon. Before Alcon, he was the lead engineer and a core member at Caltech-USC medical micropump research startups to develop the world smallest implantable micropumps for the treatment of incurable eye diseases such as glaucoma and aged macular degeneration. He had co-led fund raising and due diligence activities with more than 10 world-leading biotech, pharma, and med device firms and had directly involved in securing more than US$ 10 million of support (within overall startup group funds of more than US$ 60 million). Brian has more than 30 technical articles and more than 50 issued patents worldwide in biomedical microdevices. He earned a Ph.D. in electrical engineering and a M.S. in materials science from the USC Viterbi School of Engineering. He also holds a M.S. degree in mechanical engineering from the National Tsing Hua University, Taiwan.
Hong Yeh, PhD
Chief Operating Officer
Hong has 30+ years (post PhD) of diversified experience across R&D, manufacturing, supplier/CMO/quality/risk management, program management, and business development in consumer product and life sciences/biotech/pharma/medical device industries. With the accumulated experience from EWI, Baxter, J&J, Amgen Inc. (16+ years), and EirGenix, Hong has grown from an SME in biotech medical device areas to a successful leader focusing on business strategic planning, client/partner development, leading, and managing programs and teams in drug/device combination product commercialization and life cycle management through integration of biologics process development, drug delivery device R&D, overall manufacturing processes and business development. Hong authored three chapters of the book “Joining and Assembly of Medical Materials and Devices” published by Woodhead Publishing Limited in 2013. He has published more than 15 technical papers with numerous seminar and conference presentations. He held Chair positions and won several awards in SPE ANTEC, was a reviewer for Journal of PSE, and won numerous performance awards throughout his career. He earned his PhD and MS degrees in welding engineering and his BS degree in mechanical engineering from the Ohio State University.
Tina Feng, MBA
Co-Founder and Director of Business Development
Ms. Feng owns 10+ years of experience in business development and financial management both in the US and Taiwan. Before MicroMED, she was the financial manager in a US leading furniture trading firm, the US Furniture. She is specialized in market development, product sales, financial management, and corporate governance. In US Furniture, she has overseen the purchasing department for Asia furniture business from purchasing contact, cargo logistics, container&warehousing to product shipments. Earlier in her career, Ms. Feng had also worked at the Sheraton Grand Taipei Hotel and assisted the CFO of the hotel for her accounting and financial business managements. Before Grand Hotel, she worked at the Taiwan Suzuki Corporation and received automobile sales and marketing management experiences. Ms. Feng received her MBA degree from the Anderson Graduate School of Management at University of California, Riverside and her BA degree from the Fu-Jen University, Taiwan.
Advisory Board
Wan-Hong Lan, DDS, PhD
Medical Advisor
Wan Hong Lan, DDS, PhD, received his DDS degree from National Taiwan University in 1966 and his PhD from the Tokyo Medical Dental University (TMDU), Japan in 1981. He is one of the first seed faculty group sponsored by Taiwan government to introduce modern endodontics curriculum into NTU College of Medicine in 1975. He also served in several academic positions in NTU such as Dean at the School of Dentistry, Director at the Graduate Institute of Clinical Dentistry, and Chairperson at the Department of Dentistry. Dr. Lan is internationally known for his work on improving endodontics treatment to save patient’s natural teeth with a novel standardized process in root canal therapy. He was also the founding chairman for the Academy of Endodontology (Taiwan) and has been invited to give speeches/lectures in several world leading endodontology conferences and medical schools. Dr. Lan retired in 2006 and received the Emeritus Professor title with a lifetime honorable office in NTU Dental School. Currently, he is still very active and has been serving as the chairperson/committee member in many government associated committees for the Ministry of Health and Welfare, the Ministry of Education, the Ministry of Examination, and the Taiwan Higher Education Institutions.
TC Cheng, PhD
Tech Advisor
Tsung-Chieh Cheng is an expert and owns 20+ years of experiences in the field of heat and mass flow, MEMs clean room construction, MEMs manufacturing method, and material characteristics. He received his PhD degree from the Department of Mechanical Engineering, National Chiao Tung University. In his early career, he worked at the Tainan Service Division of the National Nano Devices Laboratory (NDL) as an associated researcher. There, he co-led the startup process for the iso-7 cleanroom facility and guided both MEMS equipment setup for later standard MEMS production process. In 2008, Dr. Cheng joined the Department of Mechanical Engineering at the National Kaohsiung University of Applied Sciences (KUAS) as an assistant professor. In KUAS, he served as an operation team leader at the MEMS center from 2009 to 2011 and, later, as a director of the Innovative Incubation Center of KUAS from 2012 to 2015. Dr. Cheng has published more than 130 technical papers and 10 patents worldwide in MEMS and materials science field. He was promoted to full professor in 2016 and the Deputy Dean of Industry-Academia Cooperation at KUAS.
JR Lai, PhD
EE Advisor
Jiunn-Ru Lai received the B.S. and Ph.D. degrees from the National Taiwan University, Taipei, Taiwan. From 2004 to 2005, he was a Postdoctoral Researcher with the Department of Electrical Engineering, National Taiwan University. From 2005 to 2006, he served as a system engineer for Intel in the pilot voice over internet protocol (VoIP) project with National Taiwan University Hospital. He was an Assistant Professor, from 2006 to 2015, and an Associate Professor, from 2015 to 2018, with the Department of Electrical Engineering, National Kaohsiung University of Applied Sciences, Taiwan. Since 2018, he has been with Department of Electrical Engineering, National Kaohsiung University of Science and Technology, Kaohsiung, Taiwan, as an Associate Professor. He received the Best Paper awards from the Taiwan Academic Network Conference (TANET) in 2016 and 2018. His research interests include embedded system design and application, mobile and wireless networking, wireless sensor network application, internet of things, and network protocol performance analysis.
James Lan, PhD
Regulatory Advisor
James received his Ph.D. degree from the School of Dentistry, the Taipei Medical University. He has 15+ years of experience in medical device R&D, quality control, and regulatory certification services. James is currently the chair and associate professor for the Department of Oral Hygiene care at the Ching Kuo Institute of Management and Health. Besides his leadership work in Ching Kuo, James has also joined the advisory committee for the Ministry of Health and Welfare to setup a new national license program to promote Dental Assistants to Dental Hygienists. Before Ching Kuo, Dr. Lan had worked in the Development Center for Biotechnology (DCB) as a senior research fellow. He also managed DCB’s incubation center sponsored by SMEA, MOEA. R.O.C. to promote biotechnology industry and coach biophama & biomedical startups. Dr. Lan also owns startup experience at Biotech One, Inc. and was the associate manager for the R&D department of the company. There, he was responsible for many product quality/regulatory programs such as biocompatible certification, sterilization validation, cleanroom certification, CE mark certification, FDA 510(k) application, FDA PMA, and tFDA medical device regulatory registration. Dr. Lan also owns a MS degree in oral biology from the National Yang-Ming University.